Suppr超能文献

颅内转移瘤切除术后立体定向放射外科治疗与全脑放疗的系统评价和荟萃分析

Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis.

作者信息

Lamba Nayan, Muskens Ivo S, DiRisio Aislyn C, Meijer Louise, Briceno Vanessa, Edrees Heba, Aslam Bilal, Minhas Sadia, Verhoeff Joost J C, Kleynen Catharina E, Smith Timothy R, Mekary Rania A, Broekman Marike L

机构信息

Cushing Neurosurgery Outcomes Center (CNOC), Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Harvard Medical School, Boston, MA, USA.

出版信息

Radiat Oncol. 2017 Jun 24;12(1):106. doi: 10.1186/s13014-017-0840-x.

Abstract

BACKGROUND

In patients with one to three brain metastases who undergo resection, options for post-operative treatments include whole-brain radiotherapy (WBRT) or stereotactic radiosurgery (SRS) of the resection cavity. In this meta-analysis, we sought to compare the efficacy of each post-operative radiation modality with respect to tumor recurrence and survival.

METHODS

Pubmed, Embase and Cochrane databases were searched through June 2016 for cohort studies reporting outcomes of SRS or WBRT after metastasis resection. Pooled effect estimates were calculated using fixed-effect and random-effect models for local recurrence, distant recurrence, and overall survival.

RESULTS

Eight retrospective cohort studies with 646 patients (238 with SRS versus 408 with WBRT) were included in the analysis. Comparing SRS to WBRT, the overall crude risk ratio using the fixed-effect model was 0.59 for local recurrence (95%-CI: 0.32-1.09, I: 3.35%, P-heterogeneity = 0.36, 3 studies), 1.09 for distant recurrence (95%-CI: 0.74-1.60, I: 50.5%, P-heterogeneity = 0.13; 3 studies), and 2.99 for leptomeningeal disease (95% CI 1.55-5.76; I: 14.4% p-heterogeneity: 0.28; 2 studies). For the same comparison, the risk ratio for median overall survival was 0.47 (95% CI: 0.41-0.54; I: 79.1%, P-heterogeneity < 0.01; 4 studies) in a fixed-effect model, but was no longer significant (0.63; 95%-CI: 0.40-1.00) in a random-effect model. SRS was associated with a lower risk of leukoencephalopathy (RR: 0.15, 95% CI: 0.07-0.33, 1 study), yet with a higher risk of radiation-necrosis (RR: 19.4, 95% CI: 1.21-310, 1 study).

CONCLUSION

Based on retrospective cohort studies, the results of this study suggest that SRS of the resection cavity may offer comparable survival and similar local and distant control as adjuvant WBRT, yet may be associated with a higher risk for developing leptomeningeal disease. Future research on SRS should focus on achieving a better understanding of the various factors that may favor SRS over WBRT.

摘要

背景

在接受手术切除的有一至三个脑转移瘤的患者中,术后治疗选择包括全脑放疗(WBRT)或对切除腔进行立体定向放射外科治疗(SRS)。在这项荟萃分析中,我们试图比较每种术后放疗方式在肿瘤复发和生存方面的疗效。

方法

检索了截至2016年6月的Pubmed、Embase和Cochrane数据库,以查找报告转移瘤切除术后SRS或WBRT结果的队列研究。使用固定效应和随机效应模型计算局部复发、远处复发和总生存的合并效应估计值。

结果

分析纳入了八项回顾性队列研究,共646例患者(238例接受SRS,408例接受WBRT)。将SRS与WBRT进行比较,使用固定效应模型时,局部复发的总体粗风险比为0.59(95%可信区间:0.32 - 1.09,I²:3.35%,P异质性 = 0.36,3项研究),远处复发为1.09(95%可信区间:0.74 - 1.60,I²:50.5%,P异质性 = 0.13;3项研究),软脑膜疾病为2.99(95%可信区间1.55 - 5.76;I²:14.4%,P异质性:0.28;2项研究)。对于相同的比较,在固定效应模型中,总生存中位数的风险比为0.47(95%可信区间:0.41 - 0.54;I²:79.1%,P异质性 < 0.01;4项研究),但在随机效应模型中不再显著(0.63;95%可信区间:0.40 - 1.00)。SRS与白质脑病风险较低相关(RR:0.15,95%可信区间:0.07 - 0.33,1项研究),但与放射性坏死风险较高相关(RR:19.4,95%可信区间:1.21 - 310,1项研究)。

结论

基于回顾性队列研究,本研究结果表明,对切除腔进行SRS在生存方面可能与辅助性WBRT相当,在局部和远处控制方面相似,但可能与发生软脑膜疾病的风险较高相关。未来关于SRS的研究应集中在更好地理解可能使SRS优于WBRT的各种因素上。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/792f/5483276/04bcdbb8e6ef/13014_2017_840_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验